Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Business and Liquidity (Details Textual)

v3.20.2
Note 1 - Nature of Business and Liquidity (Details Textual)
Sep. 30, 2020
Number of Core Drug Technologies 3
Number of Drug Candidates 5
Number of Approaches to Treating Cancer of Drug Candidates 3
Animal Life Sciences, Inc [Member]  
Equity Method Investment, Ownership Percentage 10.00%